Designates May 2026 as ALS Awareness Month and expresses the Senate's support for better treatment, research, and support for people with amyotrophic lateral sclerosis.

• Describes ALS as a progressive disease with a life expectancy of 2 to 5 years after diagnosis, and notes that no cure exists.
• States that more than 5,000 people in the United States are diagnosed with ALS each year, and that military veterans are more likely to be diagnosed than people with no military service.
• Affirms Senate commitment to early access to treatments, identifying causes and risk factors, maintaining patient independence, and reducing the physical and emotional burdens of the disease.
• Commends families, caregivers, researchers, and organizations working to extend lives and develop treatments and cures.

• Judiciary Committee (Senate)

Health